What Things You Need to Pay Attention Using BPC-157

What Things You Need to Pay Attention Using BPC-157 -By Polypeptide.ltd

Authoritative source：PubChem

Introduction BPC-157 is a stabilized gastric pentapeptide isolated from human gastric juice, and BPC-157 for sale as a bodybuilding peptide to many bodybuilders.

Custom Synthesis Peptide Manufacturers

https://www.polypeptide.ltd/

BPC 157 is a partial sequence of human gastric juice protein BPC. BPC 157 is known to have great potential to speed up our body’s healing and repair. It works wonders on joints, muscles and musculature, helping them recover faster after strenuous workouts, sporting events or injuries.

BPC 157 is an excellent chemical that can help protect the body from damage.

Surprisingly, BPC 157 has shown several gastrointestinal-related benefits in addition to helping with conditions such as bone degeneration, joint pain, damaged gut, and ulcers.

BPC 157 is a compound that helps reduce inflammation, which is done by preventing several brain diseases and organ damage.

How to take BPC–157 ? Injection vs Oral?

There are two main ways to use a BPC-157 dosage: injection and oral capsules.

Depending on each individual’s preference and expectation, BPC-157 can be taken either way while delivering relatively similar effects.

If you’re uncomfortable with needles, go for the capsules. However, keep in mind that you may not absorb 100% of the BPC-157 dosage due to digestion and metabolism.

Injecting a BPC-157 dosage is a little more efficient and faster-acting. Professional athletes supposedly prefer this route of administration since injecting BPC-157 into the bloodstream and muscles can directly benefit the target injured site.

Overall, both injections and capsules provide systemic effects of a BPC-157 dosage.

What is the Right BPC-157 Dosage?

Basic dosage: 2.5-3.75 micrograms/kilogram of body weight/time/twice a day.

Custom Synthesis Peptide Manufacturers

https://www.polypeptide.ltd/

Injections: 16 syringe units/time/twice a day (injected BPC-157 must be diluted with bacteriostatic water). Please follow the instructions on the vial.

Oral capsules: maximum 500 micrograms (0.5 milligrams)/day/2 times a day.

BPC-157 is a prescription pharmaceutical in some states, so consult your doctor before buying BPC-157 powder to decide if you’re qualified for drug use.

You should take BPC-157 consistently daily for up to 3 months after buying BPC-157, then give it a break for one month.

Below is the BPC-157 single dosage based on body weight: Body weight (kg)

2.5 micrograms/kilogram

3.75 micrograms/kilogram

60

150 micrograms

225 micrograms

70

175 micrograms

260 micrograms

80

200 micrograms

300 micrograms

90

225 micrograms

340 micrograms

100

250 micrograms

375 micrograms

Reference citations [1]Jelovac, Nikola; Sikiric, Predrag; Rucman, Rudolf; Petek, Marijan; Marovic, Anton; Perovic, Darko; Seiwerth, Sven; Mise, Stjepan; Turkovic, Branko; Dodig, Goran; Miklic, Pavle; Buljat, Gojko; Prkacin, Ingrid (1999). “Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats”. European Journal of Pharmacology. 379 (1): 19–31. doi:10.1016/S0014-2999(99)00486-0. PMID 10499368.

[2]“PUBCHEM”. pubchem.ncbi.nlm.nih.gov. Retrieved 1 March 2021.

[3]“2022 Prohibited List: SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION)” (PDF). World Anti-Doping Agency.

WADA. Retrieved 21 February 2022.

Custom Synthesis Peptide Manufacturers

https://www.polypeptide.ltd/

[4] Sikiric, P.; Seiwerth, S.; Brcic, L.; Blagaic, A. B.; Zoricic, I.; Sever, M.; Klicek, R.; Radic, B.; Keller, N.; Sipos, K.; Jakir, A.; Udovicic, M.; Tonkic, A.; Kokic, N.; Turkovic, B.; Mise, S.; Anic, T. (2006). “Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia).

Full and distended stomach, and vascular response”.

Inflammopharmacology.

14 (5–6): 214–21. doi:10.1007/s10787-006-1531-7. PMID 17186181. S2CID 24132425.

[5]Cerovecki, Tomislav; Bojanic, Ivan; Brcic, Luka; Radic, Bozo; Vukoja, Ivan; Seiwerth, Sven; Sikiric, Predrag (September 2010). “Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat”. Journal of Orthopaedic Research.

28 (9): 1155–1161. doi:10.1002/jor.21107. ISSN 1554-527X. PMID 20225319. S2CID 2208 5833.

[6] Sikiric, P; Seiwerth, S; Rucman, R; Kolenc, D; Vuletic, LB; Drmic, D; Grgic, T; Strbe, S; Zukanovic, G; Crvenkovic, D; Madzarac, G; Rukavina, I; Sucic, M; Baric, M; Starcevic, N; Krstonijevic, Z; Bencic, ML; Filipcic, I; Rokotov, DS; Vlainic, J (2016). “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications”.

Current Neuropharmacology .14 (8): 857–865. doi:10.2174/1570159×13666160502153022. PMC 5333585. PMID 271388 87.

[7]Gwyer D, Wragg NM, Wilson SLGastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.Cell Tissue Res.(2019-Aug).

[8]Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migrationJ Appl Physiol (1985).(2011 Mar).

[9]Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010 Sep;28(9):1155-61. doi: 10.1002/jor.21107. PMID: 20225319.

[10]Japjec M, Horvat Pavlov K, Petrovic A, Staresinic M, Sebecic B, Buljan M, Vranes H, Giljanovic A, Drmic D, Japjec M, Prtoric A, Lovric E, Batelja Vuletic L, Dobric I, Boban Blagaic A, Skrtic A, Seiwerth S, Predrag SStable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.Biomedicines.(2021-Oct-27).

[11]Sven Seiwerth, Marija Milavic, Jaksa Vukojevic, Slaven Gojkovic, Ivan Krezic, Lovorka Batelja Vuletic, Katarina Horvat Pavlov, Andrea Petrovic, Suncana Sikiric, Hrvoje Vranes, Andreja Prtoric, Helena Zizek, Tajana Durasin, Ivan Dobric, Mario Staresinic, Sanja Strbe, Mario Knezevic, Marija Sola, Antonio Kokot, Marko Sever, Custom Synthesis Peptide Manufacturers

https://www.polypeptide.ltd/

Eva Lovric, Anita Skrtic, Alenka Boban Blagaic, Predrag SikiricStable Gastric Pentadecapeptide BPC 157 and Wound HealingFront Pharmacol.(2021 Jun 29).

[12]Huang BS, Huang SC”Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro”.Life Sci. 2022 Dec 1;310:121072. doi: 10.1016/j.lfs.2022.121072. Epub 2022 Oct 10.PMID: 36228773.

[13]Gamulin O, Oroz K, Coric L”Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157″Biomedicines.

2022 Dec 4;10(12):3130. doi: 10.3390/biomedicines10123130.PMID: 36551886.

[14]Zemba Cilic A, Zemba M”BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling “Negative-Like” Symptoms of Schizophrenia”.Biomedicines.

2022 Jun 21;10(7):1462. doi: 10.3390/biomedicines10071462.PMID: 35884767.

[15]Perovic D, Milavic M, Dokuzovic S”Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy”.Curr Issues Mol Biol. 2022 Apr 27;44(5):1901-1927. doi: 10.3390/cimb44050130.PMID: 35678659.

[16]Jung YH, Kim H, Kim H, Kim E, Baik J, Kang H.”The anti-nociceptive effect of BPC-157 on the incisional pain model in rats.”J Dent Anesth Pain Med. 2022 Apr;22(2):97-105. doi: 10.17245/jdapm.2022.22.2.97. Epub 2022 Mar 25. PMID: 35449779

Custom Synthesis Peptide Manufacturers

https://www.polypeptide.ltd/